George W. Williams

Dr. George W. Williams


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
RCRabail Arif Chaudhry
Rabail Arif Chaudhry
JZJohn Zaki
John Zaki
RWRobert Wegner
Robert Wegner
GPGreesha Pednekar
Greesha Pednekar
ATAlex Tse
Alex Tse
GWGeorge W. Williams
George W. Williams

30 September 2020 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
TMTalha Mubashir
Talha Mubashir
AAAbdul A. Arif
Abdul A. Arif
PEPrince Ernest
Prince Ernest
VMVahed Maroufy
Vahed Maroufy
RCRabail Chaudhry
Rabail Chaudhry
GWGeorge W. Williams
George W. Williams
BACKGROUND: Acute traumatic spinal cord injuries (SCIs) often result in impairments in respiration that may lead to a sequelae of pulmonary dysfunction, increased risk of infection, and death. The optimal timing for tracheostomy in patients with acute SCI is currently unknown. This systematic review and meta-analysis aims to assess the optimal timing of tracheostomy in SCI patients and evaluate the potential benefits of early versus late tracheostomy. METHODS: We searched Medline, PubMed, Embase, Cochrane Central, Cochrane Database of Systematic Reviews, and PsycINFO for published studies. We included studies on adults with SCI who underwent early or late tracheostomy and compared outcomes. In addition, studies that reported a concomitant traumatic brain injury were excluded. Data were extracted independently by 2 reviewers and copied into R software for analysis. A random-effects meta-analysis was performed to estimate the pooled odds ratio (OR) or mean difference (MD). RESULTS: Eight studies with a total of 1220 patients met our inclusion criteria. The mean age and gender between early and late tracheostomy groups were similar. The majority of the studies performed an early tracheostomy within 7 days from either time of injury or tracheal intubation. Patients with a cervical SCI were twice as likely to undergo an early tracheostomy (OR = 2.13; 95% confidence interval [CI], 1.24–3.64; P = .006) compared to patients with a thoracic SCI. Early tracheostomy reduced the mean intensive care unit (ICU) length of stay by 13 days (95% CI, −19.18 to −7.00; P = .001) and the mean duration of mechanical ventilation by 18.30 days (95% CI, −24.33 to −12.28; P = .001). Although the pooled risk of in-hospital mortality was lower with early tracheostomy compared to late tracheostomy, the results were not significant (OR = 0.56; 95% CI, 0.32–1.01; P = .054). In the subgroup analysis, mortality was significantly lower in the early tracheostomy group (OR = 0.27; P = .006). Finally, no differences in pneumonia between early and late tracheostomy groups were noted. CONCLUSIONS: Based on the available data, patients with early tracheostomy within the first 7 days of injury or tracheal intubation had higher cervical SCI, shorter ICU length of stay, and shorter duration of mechanical ventilation compared to late tracheostomy. The risk of in-hospital mortality may be lower following an early tracheostomy. However, due to the quality of studies and insufficient clinical data available, it is challenging to make conclusive interpretations. Future prospective trials with a larger patient population are needed to fully assess short- and long-term outcomes of tracheostomy timing following acute SCI.

1 October 2017 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
RCRabail Arif Chaudhry
Rabail Arif Chaudhry
RWRobert Wegner
Robert Wegner
JZJohn F. Zaki
John F. Zaki
GPGreesha Pednekar
Greesha Pednekar
ATAlex Tse
Alex Tse
GWGeorge W. Williams
George W. Williams

1 August 2017 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
GWGeorge W. Williams
George W. Williams
BSBairavi Shankar
Bairavi Shankar
EKEliana M. Klier
Eliana M. Klier
ACAlice Z. Chuang
Alice Z. Chuang
SMSalma El Marjiya-Villarreal
Salma El Marjiya-Villarreal
ASAnne B. Sereno
Anne B. Sereno

12 June 2025 in JCI Insight
Verified
Journal Article
Open access
PDF file
BBBentley Bobrow
Bentley Bobrow
SLSamuel D. Luber
Samuel D. Luber
PPPaul Potnuru
Paul Potnuru
KFKatherine Figarella
Katherine Figarella
JKJieun Kim
Jieun Kim
HEHolger Eltzschig
Holger Eltzschig
Hypoxia-inducible factors (HIFs) promote lung protection and pathogen eradication during acute lung injury. We, therefore, tested the theory that pharmacologic stabilization of HIFs dampens lung injury during SARS-CoV-2 pneumonia. Initial studies in murine SARS-CoV-2 models showed improved outcomes after treatment with the FDA-approved HIF stabilizer vadadustat. Subsequent studies in genetic models implicated alveolus-expressed Hif1a in mediating lung protection. Therefore, we performed a randomized, double-blinded, multicenter phase II trial in patients admitted for SARS-CoV-2 infection and concomitant hypoxia (SpO 2 ≤ 94%). Patients ( n = 448) were randomized to oral vadadustat (900 mg/day) or placebo for up to 14 days. Safety events were similar between the 2 groups. Vadadustat treatment induced surrogate HIF target genes. The primary outcome of severe lung injury requiring high oxygen support on day 14 occurred in 43 patients in the vadadustat group and 53 patients in the placebo group (estimated probability, 13.3% vs. 16.9%). Among patients with baseline fraction of inspired oxygen of 80% or higher ( n = 106), the estimated probability of the primary outcome was 12.1% (vadadustat) versus 79.1% (placebo), indicating an even greater benefit in patients with more severe baseline hypoxia. HIF1A is a likely therapeutic target during SARS-CoV-2–associated lung injury. Robust clinical trials of HIF stabilizers during pathogen-associated lung injury are warranted.

30 November 2016 in Neurocritical Care
Verified
Journal Article
Closed access
PDF file
RCRabail Arif Chaudhry
Rabail Arif Chaudhry
SBSachin Batra
Sachin Batra
OMOmar L. Mancillas
Omar L. Mancillas
RWRobert Wegner
Robert Wegner
NGNavneet Grewal
Navneet Grewal
GWGeorge W. Williams
George W. Williams